Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet
-
Published:2023-10-03
Issue:14
Volume:101
Page:
-
ISSN:0028-3878
-
Container-title:Neurology
-
language:en
-
Short-container-title:Neurology
Author:
Monteiro Cecilia1, Toth Balazs1, Brunstein Flavia1, Bobbala Ashwini1, Datta Seema1, Ceniceros Ryan1, Sanabria Bohorquez Sandra M.1, Anania Veronica G.1, Wildsmith Kristin R.1, Schauer Stephen P.1, Lee Julie1, Dolton Michael J.1, Ramakrishnan Vidya1ORCID, Abramzon Daniel1, Teng Edmond1, Aggarwal Puja, Agronin Marc, Ala Thomas, Arnold Jennifer, Arnold Thomas, Toledo Miquel Baquero, Gonzalez Rafael Blesa, Rovira Merce Boada, Bond Wendy, Brody Mark, Ceccaldi Mathieu, Czarnecki Maciej, Del Olmo Rodriguez Antonio, Dobryniewski Jacek, Dubois Bruno, Edwards Keith, Forchetti Concetta, Goldstein Mark, Goodman Ira, Cezara Roxana Hanta, Ilkowski Jan, Justiz William, KrolakSalmon Pierre, Krupinski Jerzy, Pascual Lamberto Landete, Levy Richard, Bisa Alberto Lleo, Losk Scott, MaldonadoRobles Orlando, Marshall Gad, Martinez Walter, McAllister Peter, McElveen William Alvin, McGinnis Scott, Mickielewicz Anatol, Mollion Helene, Murphy Cynthia, Nair Anil, Nair Malini, Omidvar Omid, Oskooilar Nader, Patel Paayal, Porsteinsson Anton, Ratajczak Marcin, Riddle Meghan, Rosenbloom Michael, Russell David, Salloway Stephen, Del Valle Diaz Raquel Sanchez, Sha Sharon, Shah Raj, Sharma Sanjiv, Smith William, Sood Ajay, Stein Lee, Stoukides John, Thein Stephen, Watson David, Weisman David, Zboch Marzena, Zielinski Tomasz, ,
Affiliation:
1. From Genentech, Inc., South San Francisco, CA.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Neurology (clinical)
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|